ASCIA News
-
ASCIA 2019 Conference deadlines have been extended to 22 July
In response to several requests, the ASCIA 2019 earlybird registration and abstract submission deadline has been extended by one more week, to midnight on Monday 22nd July. Please note that no further extensions will be possible. To register at the discounted earlybird rate... -
ASCIA 2019 Conference earlybird registration and abstract submission closes next Monday 15 July
8 July 2019: Discounted earlybird registration and abstract submission both close at midnight AEST next Monday 15 July 2019. To register go to https://www.ascia2019.com/registration.php To submit an abstract go to https://www.ascia2019.com/abstracts.php To view the program g... -
New ASCIA article on Egg Allergy and Influenza Vaccination
5 July 2019: People with egg allergy may be safely vaccinated with the influenza (flu) vaccine. Vaccination is an important method to reduce the risk of developing infectious diseases, including the flu, which is a major cause of illness and deaths worldwide. With the flu se... -
New ASCIA article on Food Protein-Induced Allergic Proctocolitis (FPIAP)
5 July 2019: Food protein-induced allergic proctocolitis (FPIAP) is a type of delayed inflammatory non-IgE mediated gut food allergy. Symptoms usually start at one to four weeks of age and range from having blood and/or mucous in bowel movements, to blood stained loose stool... -
Nip Allergies in the Bub for food allergy prevention
3 July 2019: Last week the National Allergy Strategy launched the Nip Allergies in the Bub food allergy prevention project, which is funded by the Australian Government Department of Health. The Nip Allergies in the Bub website www.preventallergies.org.au and other resources... -
Novalac Allergy infant formula supply update
14 June 2019: Bayer Australia Ltd (Bayer) is advising healthcare professionals and consumers that limited stock of Novalac Allergy rice protein based formula will be available and released to pharmacies in Australia during June, July and August. Intermittent supply and limit... -
Order of Australia award for Professor Constance (Connie) Katelaris AM
11 June 2019: It is with great pleasure that we confirm that an Order of Australia has been awarded to Professor Constance Katelaris AM, in recognition of her significant service to medicine in the field of immunology and allergy. Professor Constance Katelaris AM has made su... -
Probiotic and egg OIT study in Victoria
31 May 2019: The Murdoch Children’s Research Institute (MCRI) in Victoria is conducting a trial to evaluate probiotic and egg oral immunotherapy (OIT), which is a possible new treatment for egg allergy. This trial is currently recruiting children and teenagers aged between 5...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information.Verify here.